Stay updated with breaking news from Massimo Cristofanilli. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Weill Cornell Medicine researchers received a $2.4 million grant from the U.S. Department of Defense Breast Cancer Research Program to validate a new blood test for the early detection of breast cancer.Researchers are evaluating Syantra DX Breast Can
STIC CTC trial data published this November 2023 in the Journal of Clinical Oncology (JCO) demonstrate that CTC-guided treatment decision confers superior...
Weill Cornell Medicine researchers received a $2.4 million grant from the U.S. Department of Defense Breast Cancer Research Program to validate a new blood test for the early detection of breast cancer.
/PRNewswire/ -- Syantra announced today that it has obtained CE marking for the Syantra DXTM Breast Cancer test. Syantra DXTM Breast Cancer is a minimally...
Datar Cancer Genetics, a world leader in non-invasive cancer screening and diagnostics, today announced that it had designated Dr. Massimo Cristofanilli, a